Trex standardizes radiographic, R/F systems
X-ray vendor Trex Medical this month announced a new name for its radiographic and R/F product line that reflects component changes the company has made to its systems. The Danbury, CT-based firm’s Heritage Series consists of standardized versions
X-ray vendor Trex Medical this month announced a new name for its radiographic and R/F product line that reflects component changes the company has made to its systems. The Danbury, CT-based firms Heritage Series consists of standardized versions of the companys existing radiographic and R/F configurations, such as its general radiographic unit, designed for general office use; its orthopedic system, which features a standard table and HFQ 1000 generator; its ER device, which allows users to conduct a full range of anatomical studies; its VIP unit, which includes an integrated tube stand and film receptor; its PMT tomography system, for general purpose and tomography procedures; and its RT-125 device, designed for pediatric applications. The series also includes Trexs 4000M digital chest unit and its 2200I digital radiographic/fluoroscopic device.
With the Heritage Series, Trex consolidates its product line, using the same components across all its divisions. This shift centralizes Trexs manufacturing operations at its Littleton, MA, facility, and produces increased economies of scale. Now-standard components include such items as the HFQ 1000 generator previously used only in Bennetts products, and a radiographic table and overhead tube stand produced by Continental. Devices in the Heritage Series will remain at their existing price points, according to Trex spokesperson John Macko.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
